Your browser doesn't support javascript.
loading
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines.
Shen, Xiaoying; Tang, Haili; McDanal, Charlene; Wagh, Kshitij; Fischer, Will; Theiler, James; Yoon, Hyejin; Li, Dapeng; Haynes, Barton F; Sanders, Kevin O; Gnanakaran, Sandrasegaram; Hengartner, Nick; Pajon, Rolando; Smith, Gale; Dubovsky, Filip; Glenn, Gregory M; Korber, Bette; Montefiori, David C.
Afiliación
  • Shen X; Department of Surgery, Duke University School of Medicine, Durham, NC, USA.
  • Tang H; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
  • McDanal C; Department of Surgery, Duke University School of Medicine, Durham, NC, USA.
  • Wagh K; Department of Surgery, Duke University School of Medicine, Durham, NC, USA.
  • Fischer W; Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM USA.
  • Theiler J; Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM USA.
  • Yoon H; Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM USA.
  • Li D; Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM USA.
  • Haynes BF; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
  • Sanders KO; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
  • Gnanakaran S; Department of Medicine, Duke University Medical Center, Durham, NC, USA.
  • Hengartner N; Department of Surgery, Duke University School of Medicine, Durham, NC, USA.
  • Pajon R; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
  • Smith G; Department of Medicine, Duke University Medical Center, Durham, NC, USA.
  • Dubovsky F; Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM USA.
  • Glenn GM; Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM USA.
  • Korber B; Moderna Inc., Cambridge, MA, USA.
  • Montefiori DC; Novavax, Inc., Gaithersburg, MD, USA.
bioRxiv ; 2021 Jan 29.
Article en En | MEDLINE | ID: mdl-33532764

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: BioRxiv Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: BioRxiv Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos